XNCR
Xencor Inc
Next earnings Aug 4, 2026 · consensus $-0.82 EPS, $21.3M rev
Last earnings +1.2% on 2026-05-06
$14.74
▲ +2.01%$14.74▲ +72.60%
over 1Y
L $7.00EODHDH $18.14
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.0%
1W+16.6%
1M+26.7%
3M+19.7%
YTD-1.2%
1Y+72.6%
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 20 analysts
Buy
Royalty-funded biotech with improving losses and a clean balance sheet, but cash runway and pipeline risk cap upside at $14.51.
Sources: SEC EDGAR (CIK 0001326732, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/25/2026, 2:13:03 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.